Page 2 - அறிவியல் தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioLargo strengthens balance sheet by eliminating nearly all of its convertible debt It recently paid off $406,000 in convertible debt that would have come due in August 2021 through cash and equity CEO Dennis Calvert noted that BioLargo had $7.6 million in debt just three years ago BioLargo Inc (OTCQB:BLGO) reports that it has eliminated nearly all of its convertible debt to strengthen its balance sheet. The company paid off $406,000 in convertible debt that would have come due in August 2021, through cash and equity.  Other than the debt owed by its partially-owned subsidiary Clyra Medical Technologies Inc, BioLargo said only Small Business Association and Paycheck Protection Program (PPP) loans totaling $464,000 ($314,000 of which, has been applied for forgiveness) and $50,000 of fixed-price convertible debt (due in 2023) remain on the company’s balance sheet. 

United statesOak ridgeDennis calvertClyra medical technologies incSmall business associationScience technologiesPaycheck protection programBiolargo incAdvanced oxidation systemAqueous electrostatic concentratorBiolargo engineeringஒன்றுபட்டது மாநிலங்களில்ஓக் ரிட்ஜ்டென்னிஸ் கால்வெர்ட்சிறிய வணிக சங்கம்அறிவியல் தொழில்நுட்பங்கள்